We recently published a list of Should You Buy the Dip and Follow Insiders into These 10 Stocks?. In this article, we are ...
UnitedHealth Group Inc.’s drug-benefits unit is starting to reimburse pharmacies more for dispensing brand-name medicines to ...
The PBM also announced that it will make the pharmacy experience simpler for consumers with chronic conditions by eliminating ...
Optum Rx is cutting prior authorizations on 80 drugs and updating payment models to improve reimbursements, benefiting ...
Wells Fargo analyst Stephen Baxter maintained a Buy rating on UnitedHealth (UNH – Research Report) yesterday and set a price target of $660.00.
Shares of UnitedHealth Group Incorporated (NYSE:UNH – Get Free Report) have been assigned an average rating of “Buy” from the ...
Guardian Village provides affordable housing with health services, showcasing how public-private partnerships improve ...
UnitedHealth (UNH) stock in focus as the company's Optum Rx unit introduces cost-based payment models to address pharmacy challenges. Read more here.
Optum Rx said it will similarly transition client arrangements such as employer and health plan customers - to ensure transparency and greater alignment to drug costs. It has already started ...
In the latest trading session, UnitedHealth Group (UNH) closed at $516.85, marking a +1.09% move from the previous day. The stock exceeded the S&P 500, which registered a gain of 0.08% for the day.